Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 34 (1) , 22-34
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (AG13616, AG035137, AG032554, AG022374)
- Alzheimer's Association (IIRG-09-132030)
- Research Council of Finland
- Sigrid Juselius Foundation
- Turku University Hospital
This publication has 65 references indexed in Scilit:
- Effects of ApoE4 and maternal history of dementia on hippocampal atrophyNeurobiology of Aging, 2012
- Cognition, glucose metabolism and amyloid burden in Alzheimer's diseaseNeurobiology of Aging, 2012
- Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's DiseaseBiological Psychiatry, 2010
- Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer'sBiological Psychiatry, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound BArchives of Neurology, 2009
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991